SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-17-001247
Filing Date
2017-04-28
Accepted
2017-04-28 15:58:22
Documents
10
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1719865.htm 20-F 2845595
2 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 6516
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10429
4 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10610
5 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4455
6 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4374
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3225
8 image0.jpg GRAPHIC 237185
9 image00001.jpg GRAPHIC 631
10 image00002.jpg GRAPHIC 2196
  Complete submission text file 0001178913-17-001247.txt   3216684
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36187 | Film No.: 17795263
SIC: 2870 Agricultural Chemicals